Femasys director granted options for 880 shares
Femasys Inc. director Alistair Milnes received a new stock option award.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Femasys Inc. director Alistair Milnes received a new stock option award. On 2026-06-24, he was granted options to acquire 880 shares of Femasys common stock at an exercise price of $3.67 per share, expiring on 2036-06-24. The underlying shares vest one year from the grant date, assuming continued service, and this grant brings his directly held stock options from this award to 880 options.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F1 | 880 | $0.00 | $0.00 |
Footnotes (1)
- F1. The shares underlying the stock option vest one year from the date of grant, assuming continued service.
Key Figures
Key Terms
Stock Option (Right to Buy) financial
exercise price financial
vest financial
underlying security financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did FEMY director Alistair Milnes report in this Form 4?
What is the exercise price of the new FEMY stock options?
When do Alistair Milnes’s FEMY options vest and expire?
Was the FEMY Form 4 transaction a purchase or a grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.